MAS Omni IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, REF: OPRO-101; MAS Omni IMMUNETM PRO Liquid Assayed Integrated Immunoassay Control, Sample Pack, REF: OPRO-SP Recall
MAS Omni IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, REF: OPRO-101; MAS Omni IMMUNETM PRO Liquid Assayed Integrated Immunoassay Control, Sample Pack, REF: OPRO-SP
FDA recall Class II
Ongoing
FDA lists this Class II recall for MAS Omni IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, REF: OPRO-101; MAS Omni IMMUNETM PRO Liquid Assayed Integrated Immunoassay Control, Sample Pack, REF: OPRO-SP. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0159-2027
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Aug 17, 2026
- FDA report date
- Oct 21, 2026
- Quantity in commerce
- 1366
- Distribution
- See key details
- FDA cause
- Process change control
What is being recalled?
MAS Omni IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, REF: OPRO-101; MAS Omni IMMUNETM PRO Liquid Assayed Integrated Immunoassay Control, Sample Pack, REF: OPRO-SP
Affected model & UDI checker
Search the exact identifiers published for Z-0159-2027.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| OPRO-101 | MAS Omni IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, REF: OPRO-101; MAS Omni IMMUNETM PRO Liquid Assayed Integrated Immunoassay Control, Sample Pack, REF: OPRO-SP | Check source notice | Not specified |
FDA code information
REF/UDI-DI/Lot(Expiration): OPRO-101/00884883005327/OPRO29061A(2029-06-30); OPRO-SP/00884883005358/OPRO2906SA(2029-06-30)
Why was this product recalled?
Vial-to-vial variability in MAS¿ Omni"IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, Lot OPRO29061A results in low Parathyroid Hormone (PTH) recovery, which may lead to a delay in reporting patient PTH results.
What actions did Microgenics Corporation take?
On 8/17/2026, recall notices were emailed to customers asking them to do the following: 1) If the variability of the material (PTH Analyte) exceeds your laboratory's specification, dispose of the material. of the material in accordance with local, regional, and national regulations. 2) Contact [email protected] for any additional support. 3) Customers using the affected product can continue to use the product as long as it meets their laboratory's specification and continue monitoring performance of PTH analyte. 4) This recall notice needs to be passed to anyone within your organization or any organization where the potentially affected lot have been transferred. 5) Retain a copy of this letter for your laboratory records. 6) Complete and return the Recall Response Form via email to [email protected] In addition, distributors were asked to do the following: - Please notify your customers of this Recall Notice using this recall notice and request they return a response to your contact information. - Firm is providing a customer response form template as a word document. Please place this letter on to your own letterhead and collect responses from your customers on that customer response form. Please note, customers should provide their response directly to your contact information. If you have any additional questions regarding this Recall Notice, contact the firm at 1-800-232-3342 (USA and Canada only) or 510-979-5000 (International), option 2, then option 3 or by email: [email protected]
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0159-2027
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 19, 2026
- openFDA device recall record · Source release Nov 14, 2026 · Retrieved Nov 19, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology